Results 41 to 50 of about 662,741 (312)
Serological Elisa test development at the INEP Institute [PDF]
, 2021 The COVID-19 diagnostic tools are categorized into two main groups of Nucleic Acid (NA)- based and protein-based tests. To date, nucleic acid-based detection has been announced as the gold-standard strategy for coronavirus detection; however, protein ...
Đukić, Teodora +10 more
core
Molecular Oncology, EarlyView.Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source
, 2013 The diagnosis and clinical management of cystic echinococcosis (CE) rely on imaging and serology, the latter still having a complementary role as its accuracy in assessing cyst viability is unsatisfactory.
F. Genco +9 more
core +2 more sources
SU UN NUOVO TEST ELISA PER LO SCREENING DELLA LUE
Microbiologia Medica, 2007 -
A. Panuccio +5 more
doaj +1 more source
BMC Veterinary Research, 2020 Background Brucellosis is a zoonosis whose incidence is not declining worldwide despite the global effort to control the disease. Accurate and precise diagnosis is a crucial step in any prophylaxis program but single tests to unequivocally detect animals
Adriana Trotta +7 more
doaj +1 more source
EVULATION OF INDIRECT ELISA TEST In DIAGNOSIS OF BRUCELLOSIS IN CAMELS [PDF]
Veterinary Medical Journal - Giza, 2000 A serological survey was carried out on 365 camels (Camelus dromedaries, one humped camel) in Saudi Arabia. Out of these 250 were Imported from the Sudan, 80 from the Norther Abattoir and 35 blood samples were collected om local markets in Jeddah, Saudi ...
M HAMDY
doaj +1 more source
COMP–PMEPA1 axis promotes epithelial‐to‐mesenchymal transition in breast cancer cells
Molecular Oncology, EarlyView.This study reveals that cartilage oligomeric matrix protein (COMP) promotes epithelial‐to‐mesenchymal transition (EMT) in breast cancer. We identify PMEPA1 (protein TMEPAI) as a novel COMP‐binding partner that mediates EMT via binding to the TSP domains of COMP, establishing the COMP–PMEPA1 axis as a key EMT driver in breast cancer.
Konstantinos S. Papadakos +6 more
wiley +1 more source
Sensitivity and specificity of the ELISA test.
, 2014 When all two, three or four of these recombinant proteins were tested positive, the serum sample was judged to be positive. Otherwise, it was judged to be negative.*a: MAT+&ELISA+; b: MAT+&ELISA-; c: MAT-&ELISA+; d:MAT-&ELISA-;#Sensitivity = a/(a+b ...
Patrick L. McDonough (677146) +12 more
core +1 more source
Logistic regression model between associated variables and ELISA test results.
, 2021 Logistic regression model between associated variables and ELISA test results.
Javier Perez-Orive (11268911) +7 more
core +1 more source
E2A selectively regulates TGF‐β–induced apoptosis in KRAS‐mutant non‐small cell lung cancer
Molecular Oncology, EarlyView.Ability to induce apoptosis by TGF‐β is frequently lost in advanced lung adenocarcinoma despite intact TGF‐β signaling. We identify E2A as a mutant KRAS–dependent mediator of resistance to TGF‐β–induced apoptosis. TGF‐β induces E2A via SMAD3 in mutant KRAS cells, and E2A silencing restores apoptosis and enhances radiation response in cell lines ...
Sergei Chuikov +3 more
wiley +1 more source